GDS Wealth Management increased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 116.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 32,582 shares of the semiconductor company’s stock after buying an additional 17,549 shares during the period. GDS Wealth Management’s holdings in Synopsys were worth $16,076,000 at the end of the most recent quarter.
Other institutional investors have also recently added to or reduced their stakes in the company. Norges Bank acquired a new position in shares of Synopsys during the second quarter worth $647,964,000. Ameriprise Financial Inc. raised its position in Synopsys by 29.1% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after purchasing an additional 585,494 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Synopsys by 177.5% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 865,987 shares of the semiconductor company’s stock worth $427,269,000 after buying an additional 553,924 shares during the period. Ninety One UK Ltd bought a new stake in shares of Synopsys in the 3rd quarter valued at about $249,851,000. Finally, Aspex Management HK Ltd increased its stake in shares of Synopsys by 106.0% in the second quarter. Aspex Management HK Ltd now owns 645,895 shares of the semiconductor company’s stock valued at $331,137,000 after buying an additional 332,364 shares during the period. 85.47% of the stock is owned by institutional investors.
Insider Transactions at Synopsys
In other news, insider Janet Lee sold 250 shares of the firm’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider owned 11,959 shares in the company, valued at $6,338,270. This trade represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 4,157 shares of company stock worth $1,945,036 in the last 90 days. 0.62% of the stock is currently owned by company insiders.
Synopsys Stock Down 1.6%
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.Synopsys’s revenue for the quarter was up 37.8% on a year-over-year basis. During the same period in the prior year, the firm earned $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, research analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on the company. Piper Sandler lowered Synopsys from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $602.00 to $520.00 in a research note on Tuesday, January 13th. Wells Fargo & Company boosted their price target on shares of Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a research report on Thursday, December 11th. Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. Rosenblatt Securities raised shares of Synopsys from a “neutral” rating to a “buy” rating and lowered their target price for the stock from $605.00 to $560.00 in a research note on Tuesday, December 9th. Finally, KeyCorp upped their price target on shares of Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $553.57.
Get Our Latest Stock Report on Synopsys
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
